Examining an Antioxidant Biostimulating Treatment for Dark, Postinflammatory Hyperpigmentation-Prone Skin.

Area of Science:

• Dermatology and Aesthetic Medicine
• Cosmetic Science

Background:

• Traditional skin rejuvenation treatments like chemical peels and biostimulatory therapies have limitations.
• Concerns include efficacy, safety, postinflammatory hyperpigmentation in darker skin types, and patient downtime.

Purpose of the Study:

• To introduce and evaluate an innovative Antioxidant Biostimulating Treatment (ABT).
• To assess the safety and efficacy of ABT for skin rejuvenation, especially in darker skin tones (Fitzpatrick Skin Types V-VI).

Main Methods:

• ABT integrates chemical peel and biostimulatory principles using a multi-acid delivery system.
• Controlled epidermal fissures facilitate the delivery of phytocompound antioxidant acids into the dermis.
• Safety and efficacy were evaluated in patients with Fitzpatrick Skin Types V-VI.

Main Results:

• Three ABT sessions, spaced 4 weeks apart, improved overall appearance, radiance, and skin smoothness.
• The treatment was well tolerated, with no reported postinflammatory hyperpigmentation or adverse events.
• Demonstrated efficacy and safety in patients with Fitzpatrick Skin Types V-VI.

Conclusions:

• ABT presents a safe, non-invasive skin rejuvenation option with significant benefits.
• It effectively addresses aging concerns and improves skin quality across all skin tones.
• ABT reduces the risk of adverse events associated with traditional treatments.